194 related articles for article (PubMed ID: 9914442)
1. Differential responses by neurotensin systems in extrapyramidal and limbic structures to ibogaine and cocaine.
Alburges ME; Hanson GR
Brain Res; 1999 Feb; 818(1):96-104. PubMed ID: 9914442
[TBL] [Abstract][Full Text] [Related]
2. Responses of the extrapyramidal and limbic substance P systems to ibogaine and cocaine treatments.
Alburges ME; Ramos BP; Bush L; Hanson GR
Eur J Pharmacol; 2000 Feb; 390(1-2):119-26. PubMed ID: 10708715
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment.
Alburges ME; Hoonakker AJ; Horner KA; Fleckenstein AE; Hanson GR
J Neurochem; 2011 May; 117(3):470-8. PubMed ID: 21323925
[TBL] [Abstract][Full Text] [Related]
5. Ibogaine pretreatment dramatically enhances the dynorphin response to cocaine.
Alburges ME; Hanson GR
Brain Res; 1999 Nov; 847(1):139-42. PubMed ID: 10564747
[TBL] [Abstract][Full Text] [Related]
6. Response by the neurotensin systems of the basal ganglia to cocaine treatment.
Hanson GR; Smiley P; Johnson M; Letter A; Bush L; Gibb JW
Eur J Pharmacol; 1989 Jan; 160(1):23-30. PubMed ID: 2714362
[TBL] [Abstract][Full Text] [Related]
7. Response of extrapyramidal and limbic neurotensin systems to phencyclidine treatment.
Hanson GR; Midgley LP; Bush LG; Gibb JW
Eur J Pharmacol; 1995 May; 278(2):167-73. PubMed ID: 7672001
[TBL] [Abstract][Full Text] [Related]
8. Neurotensin-dopamine interactions in the substantia nigra of the rat brain.
Merchant KM; Bush LG; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1990 Nov; 255(2):775-80. PubMed ID: 2147039
[TBL] [Abstract][Full Text] [Related]
9. Effect of low doses of methamphetamine on rat limbic-related neurotensin systems.
Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
Synapse; 2015 Aug; 69(8):396-404. PubMed ID: 25963809
[TBL] [Abstract][Full Text] [Related]
10. Changes in the limbic neurotensin systems induced by dopaminergic drugs.
Merchant KM; Letter AA; Gibb JW; Hanson GR
Eur J Pharmacol; 1988 Aug; 153(1):1-9. PubMed ID: 2905662
[TBL] [Abstract][Full Text] [Related]
11. Dopamine-mediated changes in central nervous system neurotensin systems: a role for NMDA receptors.
Singh NA; Bush LG; Gibb JW; Hanson GR
Eur J Pharmacol; 1990 Oct; 187(3):337-44. PubMed ID: 2150044
[TBL] [Abstract][Full Text] [Related]
12. Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systems.
Johnson M; Bush LG; Gibb JW; Hanson GR
Eur J Pharmacol; 1991 Feb; 193(3):367-70. PubMed ID: 1675997
[TBL] [Abstract][Full Text] [Related]
13. Effects of stimulants of abuse on extrapyramidal and limbic neuropeptide Y systems.
Westwood SC; Hanson GR
J Pharmacol Exp Ther; 1999 Mar; 288(3):1160-6. PubMed ID: 10027854
[TBL] [Abstract][Full Text] [Related]
14. Microdialysis assessment of methamphetamine-induced changes in extracellular neurotensin in the striatum and nucleus accumbens.
Wagstaff JD; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1996 Aug; 278(2):547-54. PubMed ID: 8768703
[TBL] [Abstract][Full Text] [Related]
15. Response of extrapyramidal and limbic neuropeptides to fenfluramine administration: comparison with methamphetamine.
Hanson GR; Singh N; Bush L; Gibb JW
J Pharmacol Exp Ther; 1991 Dec; 259(3):1197-202. PubMed ID: 1722253
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of haloperidol on release of neurotensin in extrapyramidal and limbic systems.
Huang W; Hanson GR
Eur J Pharmacol; 1997 Jul; 332(1):15-21. PubMed ID: 9298921
[TBL] [Abstract][Full Text] [Related]
17. Responses of limbic and extrapyramidal neurotensin systems to stimulants of abuse. Involvement of dopaminergic mechanisms.
Hanson GR; Singh N; Merchant K; Johnson M; Bush L; Gibb JW
Ann N Y Acad Sci; 1992; 668():165-72. PubMed ID: 1361111
[TBL] [Abstract][Full Text] [Related]
18. Responses of the rat basal ganglia neurotensin systems to low doses of methamphetamine.
Alburges ME; Hoonakker AJ; Cordova NM; Robson CM; McFadden LM; Martin AL; Hanson GR
Psychopharmacology (Berl); 2014 Aug; 231(15):2933-40. PubMed ID: 24522333
[TBL] [Abstract][Full Text] [Related]
19. Mephedrone alters basal ganglia and limbic neurotensin systems.
German CL; Hoonakker AH; Fleckenstein AE; Hanson GR
J Neurochem; 2014 Aug; 130(3):402-7. PubMed ID: 24678634
[TBL] [Abstract][Full Text] [Related]
20. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
Singh NA; Bush LG; Gibb JW; Hanson GR
Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
